Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement From the American Heart Association

2016/11/01 by Biykem Bozkurt, David Aguilar, Anita Deswal +11 · 25 citations
Medicine · #Cardiovascular Function and Risk Factors #Heart Failure Treatment and Management #Blood Pressure and Hypertension Studies

paper · pdf · doi:10.1161/cir.0000000000000450

Citations

• Impact of Obesity on Plasma Natriuretic Peptide Levels
• Diagnosis and Management of the Metabolic Syndrome
• Harmonizing the Metabolic Syndrome

Cited by

• Coronary Microvascular Dysfunction Identifies Patients at High Risk of Adverse Events Across Cardiometabolic Diseases. [europepmc]
• Why primary obesity is a disease? [europepmc]
• Wnt5a-Mediated Neutrophil Recruitment Has an Obligatory Role in Pressure Overload-Induced Cardiac Dysfunction. [europepmc]
• Systolic Blood Pressure and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction. [europepmc]
• Red Wine Consumption and Cardiovascular Health. [europepmc]
• Correlation of Vitamin D with Inflammatory Cytokines, Atherosclerotic Parameters, and Lifestyle Factors in the Setting of Heart Failure: A 12-Month Follow-Up Study. [europepmc]
• Yes-Associated Protein (YAP) Facilitates Pressure Overload-Induced Dysfunction in the Diabetic Heart. [europepmc]
• Cardiometabolic-Based Chronic Disease, Addressing Knowledge and Clinical Practice Gaps: JACC State-of-the-Art Review. [europepmc]
• Nonlethal Inhibition of Gut Microbial Trimethylamine N-oxide Production Improves Cardiac Function and Remodeling in a Murine Model of Heart Failure. [europepmc]
• Novel Insights into the Pathogenesis and Management of the Metabolic Syndrome. [europepmc]
• IL-1 induces mitochondrial translocation of IRAK2 to suppress oxidative metabolism in adipocytes. [europepmc]
• Implications of obesity across the heart failure continuum. [europepmc]
• Renal Denervation to Treat Heart Failure. [europepmc]
• Therapeutic Potential of Quercetin to Alleviate Endothelial Dysfunction in Age-Related Cardiovascular Diseases. [europepmc]
• Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association. [europepmc]
• Rethinking pioglitazone as a cardioprotective agent: a new perspective on an overlooked drug. [europepmc]
• A Metagenome-Wide Association Study of the Gut Microbiome and Metabolic Syndrome. [europepmc]
• Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations. [europepmc]
• State of Knowledge on Molecular Adaptations to Exercise in Humans: Historical Perspectives and Future Directions. [europepmc]
• Interpretable machine learning for 28-day all-cause in-hospital mortality prediction in critically ill patients with heart failure combined with hypertension: A retrospective cohort study based on medical information mart for intensive care database-IV and eICU databases. [europepmc]
• Comorbidities of Keloid and Hypertrophic Scars Among Participants in UK Biobank. [europepmc]
• Anthropometric measures and adverse outcomes in heart failure with reduced ejection fraction: revisiting the obesity paradox. [europepmc]
• Emerging healthy lifestyle factors and all-cause mortality among people with metabolic syndrome and metabolic syndrome-like characteristics in NHANES. [europepmc]
• Obesity, Cardiorespiratory Fitness, and Cardiovascular Disease. [europepmc]
• Targeting HDAC6 to treat heart failure with preserved ejection fraction in mice. [europepmc]